BioNTech SE ADR Rises Thursday, Outperforms Market

Dow Jones2022-09-23

DJ BioNTech SE ADR Rises Thursday, Outperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

The BioNTech SE ADR (BNTX) rallied 1.37% to $130.00 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.84% to 3,757.99 and Dow Jones Industrial Average falling 0.35% to 30,076.68. BioNTech SE ADR closed $244.58 short of its 52-week high ($374.58), which the company achieved on November 29th.

The ADR underperformed when compared to some of its competitors Thursday, as AbbVie Inc. $(ABBV)$ rose 1.92% to $143.01 and Amgen Inc. $(AMGN)$ rose 1.47% to $227.75. Trading volume (1.0 M) eclipsed its 50-day average volume of 874,916.

Data source: Dow Jones Market Data, FactSet. Data compiled September 22, 2022.

 

(END) Dow Jones Newswires

September 22, 2022 16:41 ET (20:41 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment